- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Managing Partial Response: Augmentation Strategies In MDD
Persistent residual symptoms (e.g., sleep disturbances, cognitive symptoms) have known interference on quality of life and functioning of individuals with major depressive disorder (MDD) who respond to or remit from antidepressant treatment.1 Understanding the inherent challenges in symptom recognition and subsequent treatment, clinicians are tasked with finding optimal symptom relief in aiding patients on their journey towards functional recovery.
In this webinar, Dr. Alex Matushek moderates an enlightening discussion on the current state of clinical guidelines in the treatment framework of depression partial response management with Dr. Roueen Rafeyan. They will reflect on recent meta-analyses and current practice guidelines highlighting the optimization of pharmacotherapy to improve outcomes. Join us for this unique opportunity to learn and grow as we all strive to improve the quality of life of those impacted!
References:
1. Zajecka J, et al. Residual Symptoms in Major Depressive Disorder: Prevalence, Effects, and
Management. J Clin Psychiatry. 2013;74(4): 407-414.Featuring
Roueen Rafeyan, MD
Psychiatrist & Chief Medical Officer for Gateway Foundation Addiction Treatment Centers and an Assistant Professor of Psychiatry at the Feinberg School of Medicine, Northwestern University
MoreRoueen Rafeyan, MD has been a trailblazer in the field of Addiction Medicine for over 20 years, having served as a medical director for psychiatric and substance use programs at leading Illinois healthcare institutions including Rush, Michael Reese, Resurrection and Presence Behavioral Health. In addition to Dr. Rafeyan’s extensive medical experience, he is also a diplomate of the American Board of Psychiatry and Neurology and the American Society of Addiction Medicine. He is currently on the faculty at Northwestern University and an active member of the American Medical Association, American Psychiatry Association, Illinois Psychiatric Society and Illinois State Medical Society.Alex Matushek, PharmD, MBA (OPDC)
Medical Science Liaison
Roueen Rafeyan, MD is a paid consultant of Otsuka Pharmaceutical Development &
Commercialization, Inc.
Alex Matushek, PharmD, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization,
Inc.Related Events
-
Clinical Perspectives on the Impact of Agitation in Alzheimer’s Dementia Among the Hispanic Community
September 18 12:00 pm to 1:00 pm
Registration
Related Resources
-
Rural Minds – Mental Health in Rural America, Jeff Winton
Podcast Episode July 24, 2024Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on mental health in rural America with special guest, Jeff Winton (Founder of Rural Minds). During this episode, Jeff…
-
Multiple States Easing Formulary Restrictions On Antipsychotics
Article July 24, 2024Nevada can now be added to the growing list of states that have enacted legislation to exempt antipsychotics from step therapy (ST) and prior authorization (PA) protocols. The legislation (Nevada…
-
Practical Application of Wellness Strategies for Individuals in Underserved Communities with Major Depressive Disorder (MDD) & Post-Traumatic Stress Disorder (PTSD)
On-Demand Webinar July 12, 2024Approximately 50 million United States adults are living with a mental illness, with 21 million having depression and 13 million with post-traumatic stress disorder.1-4 Minority individuals are among these prevalence…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: